Computational analysis of novel drugs designed for use as acetylcholinesterase inhibitors and histamine H3 receptor antagonists for Alzheimer's disease by docking, scoring and de novo evolution

By                  

Molecular Medicine Reports, Vol. 5, Iss. 4, 2012-01 ,pp. : 1043-1048

Spandidos Publications

Access to resources Recommend Favorite

Impact of Surgical Palliation on Quality of Life in Patients with Advanced Malignancy: Results of the Decisions and Outcomes in Palliative Surgery (DOPS) Trial

By Podnos Yale   Juarez Gloria   Pameijer Colette   Choi Kyong   Ferrell Betty   Wagman Lawrence  

Annals of Surgical Oncology, Vol. 14, Iss. 2, 2007-02 ,pp. : 922-928

Springer Publishing Company

Access to resources Recommend Favorite

Identification of histamine receptor subtypes in skeletal myogenesis

By                

Molecular Medicine Reports, Vol. 11, Iss. 4, 2015-01 ,pp. : 2624-2630

Spandidos Publications

Access to resources Recommend Favorite

The impact of breast cosmetic and functional outcomes on quality of life: long-term results from the St. George and Wollongong randomized breast boost trial

By Hau Eric  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 115-123

Springer Publishing Company

Access to resources Recommend Favorite

The intracellular histamine antagonist, N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine.HCl, may potentiate doxorubicin in the treatment of metastatic breast cancer: Results of a pilot study

By Brandes Lorne   Bracken Susan  

Breast Cancer Research and Treatment, Vol. 49, Iss. 1, 1998-05 ,pp. : 61-68

Springer Publishing Company

Access to resources Recommend Favorite